Effect of a Cardiac Rehabilitation Program on Chronic Heart Failure Patients in Yaoundé, Cameroon (CARECA-CHF)

Yaounde Central Hospital

Status: Unknown

Conditions: Chronic Heart Failure (CHF)

Treatments: Other: CHF Patients

Study type: Interventional

Funder types: Other

Identifiers

NCT04790214

CARECA-CHF

Details and patient eligibility

About

CARECA-CHF study is a non-randomized, prospective, single-arm study, enrolled ambulatory patients with stable chronic heart failure [New York Heart Association (NYHA) class II/III]. Patients will be followed-up during a period of 06-08 weeks. The aim of this study is to assess the effect of a cardiac rehabilitation program on patients with stable chronic heart failure in Yaoundé, Cameroon.

Full description

CARECA-CHF study is a non-randomized, prospective, single-arm study, multicentric study. Patients with stable chronic heart failure [New York Heart Association (NYHA) class II/III] will be enrolled ambulatory. The program will take place during a period of 06-08 weeks.

The aim of this study is to assess the effect of a cardiac rehabilitation program on patients with stable chronic heart failure in a resource-limited country.

Enrollment: 30 estimated patients

Sex: All

Ages: 21 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with stable chronic heart failure confirmed by a cardiac ultrasound and whose severity is rated stage II or III of NYHA followed at Yaoundé central hospital and Yaoundé general hospital;
• Stable under treatment;
• Whose cardiac ultrasound is less than six months old;
• Having given his free and informed consent.

Exclusion criteria

• Poor adherence to the cardiac rehabilitation program activities;
• Patients lost insight the program;
• Withdrawal of informed consent.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

Stable CHF patients

Experimental group

Description:

Stable CHF patients on stage II/III based on the New York Heart Failure classification

Treatment:

Other: CHF Patients